Clinical and pharmacokinetic study of PM00104 in Phase II (Zalypsis) in Patients with Advanced Urothelial Carcinoma and / or Metastatic Progress After a First Line Platinum Based Treatment. [Estudio Clínico y Farmacocinético en Fase II de PM00104 (Zalypsis) en Pacientes con Carcinoma Urotelial Avanzado y/o Metastático que Progresa Después de una Primera Línea de Tratamiento Basado en Platino.]

Trial Profile

Clinical and pharmacokinetic study of PM00104 in Phase II (Zalypsis) in Patients with Advanced Urothelial Carcinoma and / or Metastatic Progress After a First Line Platinum Based Treatment. [Estudio Clínico y Farmacocinético en Fase II de PM00104 (Zalypsis) en Pacientes con Carcinoma Urotelial Avanzado y/o Metastático que Progresa Después de una Primera Línea de Tratamiento Basado en Platino.]

Completed
Phase of Trial: Phase II

Latest Information Update: 01 Apr 2014

At a glance

  • Drugs PM 00104 (Primary)
  • Indications Urogenital cancer
  • Focus Therapeutic Use
  • Sponsors PharmaMar
  • Most Recent Events

    • 28 Mar 2012 Status changed from recruiting to completed.
    • 27 Jun 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top